References
- Joshi KK, Nerurkar RP. Anti-inflammatory effect of the serratiopeptidase – rationale or fashionable: a study in rat paw oedema model induced by the carrageenan. Indian J Physiol Pharmacol 2012;56:367–74
- Panagariya A, Sharma A. A preliminary trial of serratiopeptidase in patients with carpal tunnel syndrome. J Assoc Physicians India 1999;47:1170–2
- Kee W, Tan S, Lee V, Salmon Y. The treatment of breast engorgement with serrapeptase (Danzen): a randomised double-blind controlled trial. Singapore Med J 1989;30:48–54
- Nakamura S, Hashimoto Y, Mikami M, et al. Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease. Respirology 2003;8:316–20
- Al-Khateeb TH, Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. Int J Oral Maxillofac Surg 2008;37:264–8
- Rath G, Johal ES, Goyal AK. Development of serratiopeptidase and metronidazole based alginate microspheres for wound healing. Artif Cells Blood Substit Immobil Biotechnol 2011;39:44–50
- Sandhya KV, Devi GS, Mathew ST. Liposomal formulations of serratiopeptidase: in vitro studies using PAMPA and caco-2 models. Mol Pharm 2007;5:92–7
- Mazzone A, Catalan M, Costanzo M. Evaluation of serratiopeptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double blind, randomized trial versus placebo. J Int Med Res 1990;18:379–88
- Mahato RI, Narang AS, Thoma L, Miller DD. Emerging trends in oral delivery of peptide and protein drugs. Crit Rev Ther Drug Carrier Syst 2003;20:153–214
- Nirale N, Menon M. Topical formulations of serratiopeptidase: development and pharmacodynamic evaluation. Indian J Pharm Sci 2010;72:65–71
- Schellmann N, Deckert PM, Bachran D, et al. Targeted enzyme prodrug therapies. Mini-Rev Med Chem 2010;10:887–904
- Appel E, Rabinkov A, Neeman M, et al. Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma. J Drug Target 2011;19:326–35
- Heidari Majd M, Asgari D, Barar J, et al. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles. J Drug Target 2013;21:328–40
- Kumar A, Zhang X, Liang X-J. Gold nanoparticles: emerging paradigm for targeted drug delivery system. Biotechnol Adv 2013;31:593--606
- Singh R, Lillard JW, Jr Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009;86:215–23
- Krukemeyer MG, Krenn V, Jakobs M, Wagner W. Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetite-dextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets sarcoma treatment in progress. J Drug Target 2012;20:185–93
- Kumar S, Mohan U, Kamble AL, et al. Cross-linked enzyme aggregates of recombinant Pseudomonas putida nitrilase for enantioselective nitrile hydrolysis. Bioresour Technol 2010;101:6856–8
- Verma M, Barrow C, Puri M. Nanobiotechnology as a novel paradigm for enzyme immobilisation and stabilisation with potential applications in biodiesel production. Appl Microbiol Biotechnol 2013;97:23–39
- Chen J-P, Yang P-C, Ma Y-H, et al. Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle. Int J Nanomedicine 2012;7:5137–49
- Chen JP, Yang PC, Ma YH. Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator. Carbohydr Polym 2011;84:364–72
- Bi F, Zhang J, Su Y, et al. Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis. Biomaterials 2009;30:5125–30
- Ren L, Wang X, Wu H, et al. Conjugation of nattokinase and lumbrukinase with magnetic nanoparticles for the assay of their thrombolytic activities. J Mol Catal B Enzym 2010;62:190–6
- Kalkan NA, Aksoy S, Aksoy EA, et al. Preparation of chitosan-coated magnetite nanoparticles and application for immobilization of laccase. J Appl Polym Sci 2011;123:707–16
- Kumar R, Inbaraj BS, Chen BH. Surface modification of superparamagnetic iron nanoparticles with calcium salt of poly(γ-glutamic acid) as coating material. Mater Res Bull 2010;45:1603–7
- Liang Y-Y, Zhang L-M, Li W, et al. Polysaccharide-modified iron oxide nanoparticles as an effective magnetic affinity adsorbent for bovine serum albumin. Colloid Polym Sci 2007;285:1193–9
- Petri-Fink A, Steitz B, Finka A, et al. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies. Eur J Pharm Biopharm 2008;68:129–37
- Zhuo Y, Yuan P-X, Yuan R, et al. Bienzyme functionalized three-layer composite magnetic nanoparticles for electrochemical immunosensors. Biomaterials 2009;30:2284–90
- Tang T, Fan H, Ai S, et al. Hemoglobin (Hb) immobilized on amino-modified magnetic nanoparticles for the catalytic removal of bisphenol A. Chemosphere 2011;83:255–64
- Jiang Y, Guo C, Xia H, et al. Magnetic nanoparticles supported ionic liquids for lipase immobilization: enzyme activity in catalyzing esterification. J Mol Catal B Enzym 2009;58:103–9
- Ziv-Polat O, Topaz M, Brosh T, et al. Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. Biomaterials 2010;31:741–7
- Yu C-C, Kuo Y-Y, Liang C-F, et al. Site-specific immobilization of enzymes on magnetic nanoparticles and their use in organic synthesis. Bioconjug Chem 2012;13:714–24
- Namdeo M, Bajpai SK. Immobilization of a-amylase onto cellulose-coated magnetite (CCM) nanoparticles and preliminary starch degradation study. J Mol Catal B Enzym 2009;59:134–9
- Bhattarai S, Kc R, Kim S, et al. N-hexanoyl chitosan stabilized magnetic nanoparticles: implication for cellular labeling and magnetic resonance imaging. J Nanobiotechnol 2008;6. Available from: http://www.jnanobiotechnology.com/content/6/1/1 [last accessed 2 Oct 2013]
- Wu Y, Wang Y, Luo G, et al. In situ preparation of magnetic Fe3O4-chitosan nanoparticles for lipase immobilization by cross-linking and oxidation in aqueous solution. Bioresour Technol 2009;100:3459–64
- Institute of Health, National Academy of Science. Food chemical codex. 5th ed. Washington, DC: Institute of Health, National Academy of Science; 2001: 923–4
- Li G-y, Jiang Y-r, Huang K-l, et al. Preparation and properties of magnetic Fe3O4-chitosan nanoparticles. J Alloys Comp 2008;466:451–6
- Dandamudi S, Campbell RB. The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. Biomaterials 2007;28:4673–83
- Rauf S, Ihsan A, Akhtar K, et al. Glucose oxidase immobilization on a novel cellulose acetate-polymethylmethacrylate membrane. J Biotechnol 2006;121:351–60
- Bosman IJ, Ensing K, de Zeeuw RA. Standardization procedure for the in vitro skin permeation of anticholinergics. Int J Pharm 1998;169:65–73
- Lopez RFV, Collett JH, Bentley MVLB. Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. Int J Pharm 2000;200:127–32
- Peppas N. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60:110–11
- Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Delivery Rev 2001;48:139–57
- Huang G-J, Pan C-H, Liu F-C, et al. Anti-inflammatory effects of ethanolic extract of Antrodia salmonea in the lipopolysaccharide-stimulated RAW246.7 macrophages and the λ-carrageenan-induced paw edema model. Food Chem Toxicol 2012;50:1485–93
- Sadeghi H, Hajhashemi V, Minaiyan M, et al. A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw edema in rats. Eur J Pharmacol 2011;667:396–401
- Zhu A, Yuan L, Liao T. Suspension of Fe3O4 nanoparticles stabilized by chitosan and o-carboxymethylchitosan. Int J Pharm 2008;350:361–8
- Kouassi GK, Irudayaraj J, McCarty G. Examination of cholesterol oxidase attachment to magnetic nanoparticles. J Nanobiotechnol 2005;3. Available from: http://www.jnanobiotechnology.com/content/3/1/1 [last accessed 2 Oct 2013]
- Chaleawlert-umpon S, Pimpha N. Morphology study of superparamagnetic iron oxide-chitosan nanoparticles. J Microsc Soc Thialand 2009;23:62–5
- Cao H, He J, Deng L, Gao X. Fabrication of cyclodextrin-functionalized superparamagnetic Fe3O4/amino-silane core-shell nanoparticles via layer-by-layer method. Appl Surf Sci 2009;255:7974–80
- Yamaura M, Camilo RL, Sampaio LC, et al. Preparation and characterization of (3-aminopropyl)triethoxysilane-coated magnetite nanoparticles. J Magn Magn Mater 2004;279:210–17
- Faraji M, Yamini Y, Rezaee M. Magnetic nanoparticles: synthesis, stabilization, functionalization, characterization and applications. J Iran Chem Soc 2010;7:1–37
- Talbert JN, Hotchkiss JH. Chemical modification of lactase for immobilization on carboxylic acid-functionalized microspheres. Biocatal Biotransformation 2012;30:446–54
- Hsieh H-J, Liu P-C, Liao W-J. Immobilization of invertase via carbohydrate moiety on chitosan to enhance its thermal stability. Biotechnol Lett 2000;22:1459–64
- Hu B, Pan J, Yu H-L, et al. Immobilization of Serratia marcescens lipase onto amino-functionalized magnetic nanoparticles for repeated use in enzymatic synthesis of Diltiazem intermediate. Process Biochem 2009;44:1019–24
- Zhu J, Sun G. Lipase immobilization on glutaraldehyde-activated nanofibrous membranes for improved enzyme stabilities and activities. React Funct Polym 2012;72:839–45
- Zhu H, Pan J, Hu B, et al. Immobilization of glycolate oxidase from Medicago falcata on magnetic nanoparticles for application in biosynthesis of glyoxylic acid. J Mol Catal B Enzym 2009;61:174–9
- Liu Y, Jia S, Wu Q, et al. Studies of Fe3O4-chitosan nanoparticles prepared by co-precipitation under the magnetic field for lipase immobilization. Catal Commun 2011;12:717–20
- Xu H, Song T, Bao X, et al. Site-directed research of magnetic nanoparticles in magnetic drug targeting. J Magn Magn Mater 2005;293:514–9
- Vichasilp C, Nakagawa K, Sookwong P, et al. A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonged hypoglycaemic effect. Food Chem 2012;134:1823–30
- Marroquin-Segura R, Flores-Pimentel M, Carreon-Sanchez R, et al. The effect of the aqueous extract of Helietta parvifolia A. Gray (Rutaceae) stem bark on carrageenan-induced paw oedema and granuloma tissue formation in mice. J Ethnopharmacol 2009;124:639–41
- Swami G, Pooja D, Kulhari H, et al. Surface modification of poly (l-lactic acid) microspheres for site-specific delivery of ketoprofen for chronic inflammatory disease. J Drug Target 2013;21:232–9
- Vinegar R, Schreiber W, Hugo R. Biphasic development of carrageenan edema in rats. J Pharmacol Exp Ther 1969;166:96–103
- Maheshwari M, Miglani G, Mali A, et al. Development of tetracycline-serratiopeptidase-containing periodontal gel: formulation and preliminary clinical study. AAPS PharmSciTech 2006;7:E162–71
- Chertok B, David AE, Yang VC. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography. J Control Release 2011;155:393–9